June 4, 2020 / 4:11 PM / a month ago

BRIEF-Spineguard Seeks FDA Approval To Commercialise DSG Connect

June 4 (Reuters) - Spineguard SA:

* FILES ITS “510K” DOSSIER FOR THE CLEARANCE OF ITS NEW “DSG CONNECT” PLATFORM IN THE UNITED STATES

* COMMERCIALIZATION IN UNITED STATES WILL COMMENCE AS SOON AS FILE IS VALIDATED, WHICH USUALLY TAKES 3 TO 9 MONTHS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below